furosemide

Brand: Lasix

Prototype Drug
Drug Class: loop diuretic
Drug Family: diuretic
Subclass: sulfonamide loop diuretic
Organ Systems: cardiovascularrenal

Mechanism of Action

Inhibits NKCC2 in the thick ascending limb, blocking reabsorption of Na+, K+, and Cl-; increases free water clearance; stimulates prostaglandin release causing renal vasodilation.

Na-K-2Cl cotransporter (NKCC2) in thick ascending limb of loop of Henle

Indications

  • acute pulmonary edema
  • chronic heart failure
  • edema (hepatic, renal, cardiac)
  • hypertension
  • hypercalcemia

Contraindications

  • anuria
  • sulfonamide allergy (cross-sensitivity)
  • hepatic coma with electrolyte depletion

Adverse Effects

Common

  • hypokalemia
  • hyponatremia
  • hypovolemia
  • hypotension
  • hypomagnesemia
  • metabolic alkalosis
  • ototoxicity (high IV doses)

Serious

  • ototoxicity (loop diuretic)
  • nephrotoxicity (rare)
  • severe electrolyte disturbances

Pharmacokinetics (ADME)

Absorption 10-100% oral (variable — edematous bowel absorption impaired)
Distribution wide
Metabolism minimal hepatic
Excretion renal 50% unchanged; 50% hepatic glucuronidation
Half-life 2 hours
Onset 30-60 min oral, 5-15 min IV
Peak 1-2 hours
Duration 6-8 hours oral; 2 hours IV
Protein Binding 91-97%
Vd 0.1-0.2 L/kg

Drug Interactions

Drug / Agent Mechanism Severity
aminoglycosides additive ototoxicity; additive nephrotoxicity major
lithium reduces renal lithium clearance; toxicity risk major
NSAIDs blunted diuretic response moderate
digoxin hypokalemia increases digoxin toxicity major

Nursing Considerations

  1. Weigh daily; target 0.5-1 kg/day weight loss in HF decompensation
  2. Monitor K+, Na+, Mg2+, BUN, creatinine
  3. Replace K+ when K+ <3.5 mEq/L
  4. IV dose 2x oral dose in HF (accounting for poor GI absorption)
  5. Ototoxicity: avoid rapid IV push; max 4 mg/min IV

Clinical Pearls

  • Ceiling dose effect: doubling dose above threshold does not increase natriuresis linearly — switch to IV or combination if oral inadequate
  • IV bioavailability > oral in acute HF (gut wall edema impairs oral absorption — double the oral dose for IV equivalent)

Safety Profile

Pregnancy use-with-caution
Lactation avoid
Renal Adjustment Required
Hepatic Adjustment Not required
TDM Not required

Concordance Terms

Cross-referenced clinical concepts — click any term to see all content where it appears.